These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients? Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R. J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492 [Abstract] [Full Text] [Related]
7. [Early dyskinesia with administration of clozapine (Leponex)]. Heim M, Rhein C. Nervenarzt; 1994 Jul; 65(7):486-7. PubMed ID: 7800094 [Abstract] [Full Text] [Related]
8. The prevalence of akathisia in patients receiving stable doses of clozapine. Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J. J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271 [Abstract] [Full Text] [Related]
14. The treatment of tardive dyskinesia. Raja M. Schweiz Arch Neurol Psychiatr (1985); 1996 Nov 01; 147(1):13-8. PubMed ID: 8685689 [Abstract] [Full Text] [Related]
18. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia. Ziegenbein M, Sieberer M, Calliess IT, Kropp S. Aust N Z J Psychiatry; 2005 Sep 01; 39(9):840-1. PubMed ID: 16168043 [No Abstract] [Full Text] [Related]